molecules of the month


oral CRBN-based androgen receptor degrader

preclinical eff. at 10 mpk QD (xenograft)

from previously disclosed AR molecule

Journal of Medicinal Chemistry

University of Michigan

Chemical structure of ARD-2585
1 min read

The Michigan bifunctional degrader, ARD-2585, is similar to the Arvinas molecule, ARV-110 that was recently disclosed at AACR 2021. ARV-110 is a first-in-class, potent, and orally active AR degrader in clinical development, but understandably hasn’t had much published on it yet given the competitive environment. The publication of ARD-2585 therefore provides nice insight into the properties of this class of molecules. ARD-2585 interestingly uses a rigid, linear linked piperidine-azetidine linker to connect the AR ligand and CRBN ligand, and is up to 1000x more potent than ARV-110 in AR reduction in vitro, and is active in a xenograft model at 10 mpk QD PO. 

request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.

already a member? log in: